Monopar Therapeutics Inc.
MNPR
$59.27
-$1.72-2.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 133.17% | 2,286.60% | 648.02% | 520.39% | 728.67% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -19.26% | 736.29% | 715.25% | 340.00% | 18.83% |
| Total Current Assets | 132.97% | 2,273.93% | 648.60% | 517.98% | 722.24% |
|
|
|||||
| Total Current Assets | 132.97% | 2,273.93% | 648.60% | 517.98% | 722.24% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 133.40% | 2,275.69% | 650.24% | 518.08% | 720.82% |
|
|
|||||
| Total Accounts Payable | 17.32% | 125.95% | 42.29% | 3.96% | 28.27% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -47.94% | 128.74% | 45.35% | 3.96% | 198.98% |
|
|
|||||
| Total Current Liabilities | -47.94% | 128.74% | 45.35% | 3.96% | 198.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -44.99% | 135.05% | 52.73% | 3.96% | 198.98% |
|
|
|||||
| Common Stock & APIC | 73.71% | 223.46% | 90.96% | 90.47% | 98.75% |
| Retained Earnings | -18.10% | -29.97% | -27.23% | -26.79% | -25.89% |
| Treasury Stock & Other | 265.00% | 206.36% | 834.94% | -619.05% | 355.32% |
| Total Common Equity | 150.43% | 2,761.60% | 757.13% | 616.77% | 884.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 150.43% | 2,761.60% | 757.13% | 616.77% | 884.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 150.43% | 2,761.60% | 757.13% | 616.77% | 884.95% |
|
|
|||||